Key result
The modified-LA/Ao ratio slightly improved discrimination between ACVIM stages B1 and B2 compared to the traditional LA/Ao ratio in dogs with myxomatous mitral valve disease.
Why the study?
Traditional echocardiographic LA/Ao ratio evaluates left atrial size in only one view, prompting evaluation of a modified ratio combining two views.
Does the modified-LA/Ao ratio improve the evaluation of left atrial size and differentiation of disease stages compared to traditional indices in dogs with myxomatous mitral valve disease?
Observational (n=136)
Does the modified-LA/Ao ratio improve the evaluation of left atrial size and differentiation of disease stages compared to traditional indices in dogs with myxomatous mitral valve disease?
The modified-LA/Ao ratio offers a practical and sensitive echocardiographic method to evaluate left atrial enlargement in early-stage myxomatous mitral valve disease in dogs.
May aid early MMVD staging in dogs; leaves open prospective validation before practice change.
Myxomatous mitral valve disease (MMVD) is the most common heart disease in small-breed dogs, and accurate assessment of the left atrial (LA) size is essential for diagnosis and management. The traditional echocardiographic method, LA-to-Aorta (LA/Ao) ratio, is widely used, but evaluates LA size in only one view. This study introduces a novel index-the modified-LA/Ao (M-LA/Ao) ratio-which combines two echocardiographic views to better reflect the true LA size. This study retrospectively analyzed thoracic radiographs and echocardiograms from 136 dogs, including healthy controls and dogs with MMVD classified into stages B1, B2, and C according to ACVIM guidelines. The ability of the M-LA/Ao ratio is compared to conventional indices using correlation analysis and receiver operating characteristic (ROC) curves. The M-LA/Ao ratio showed a strong correlation with existing indices and slightly improved discrimination between ACVIM stages B1 and B2, although performance between stages B2 and C was similar to the LA/Ao ratio. Intra- and interobserver variability were also acceptable. Our findings suggest that the M-LA/Ao ratio may provide a practical and sensitive method to evaluate LA enlargement in early-stage MMVD, helping clinicians detect subtle cardiac remodeling before progression to advanced disease.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) conducted an observational in Myxomatous mitral valve disease (MMVD) (n=136). Modified-LA/Ao (M-LA/Ao) ratio vs. LA-to-Aorta (LA/Ao) ratio was evaluated on Discrimination between ACVIM stages. The modified-LA/Ao ratio slightly improved discrimination between ACVIM stages B1 and B2 compared to the traditional LA/Ao ratio in dogs with myxomatous mitral valve disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: